Tatva Chintan Pharma Chem Balance Sheet Health
Financial Health criteria checks 6/6
Tatva Chintan Pharma Chem has a total shareholder equity of ₹7.4B and total debt of ₹152.3M, which brings its debt-to-equity ratio to 2.1%. Its total assets and total liabilities are ₹8.1B and ₹694.2M respectively. Tatva Chintan Pharma Chem's EBIT is ₹197.1M making its interest coverage ratio -11.6. It has cash and short-term investments of ₹148.7M.
Key information
2.1%
Debt to equity ratio
₹152.31m
Debt
| Interest coverage ratio | -11.6x |
| Cash | ₹148.73m |
| Equity | ₹7.38b |
| Total liabilities | ₹694.18m |
| Total assets | ₹8.07b |
Recent financial health updates
No updates
Recent updates
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues
Sep 26
Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00
Aug 29Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%
Jul 27Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)
May 11Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion
Apr 04These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts
Jan 26Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year
May 10Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next
Jul 28Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely
Jun 17Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings
May 03Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?
Dec 06Financial Position Analysis
Short Term Liabilities: TATVA's short term assets (₹2.5B) exceed its short term liabilities (₹678.2M).
Long Term Liabilities: TATVA's short term assets (₹2.5B) exceed its long term liabilities (₹15.9M).
Debt to Equity History and Analysis
Debt Level: TATVA's net debt to equity ratio (0.05%) is considered satisfactory.
Reducing Debt: TATVA's debt to equity ratio has reduced from 85% to 2.1% over the past 5 years.
Debt Coverage: TATVA's debt is well covered by operating cash flow (259.2%).
Interest Coverage: TATVA earns more interest than it pays, so coverage of interest payments is not a concern.